Outset Medical Q4 2023 Adj EPS $(0.59) Beats $(0.61) Estimate, Sales $30.51M Beat $30.40M Estimate
Portfolio Pulse from Benzinga Newsdesk
Outset Medical (OM) reported Q4 2023 adjusted EPS of $(0.59), surpassing the $(0.61) estimate. Sales reached $30.51M, slightly above the $30.40M estimate but marked a 4.69% decrease from the previous year.
February 21, 2024 | 9:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Outset Medical reported better-than-expected Q4 2023 earnings and sales, but sales decreased 4.69% compared to last year.
Outset Medical's better-than-expected earnings and sales for Q4 2023 could positively impact its stock price in the short term, despite the year-over-year sales decrease. The beat on both top and bottom lines suggests operational efficiency and could lead to positive investor sentiment.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100